Trial Section
Home / Trial Section / Clinical Trial| Indication | Department | Study Title | Study Phase | Investigator | Contact Person | Status |
|---|---|---|---|---|---|---|
| Solid Tumor | Gastroenterology | A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination with Anti-cancer Agents in Participants with Advanced Solid Tumours Expressing Claudin 18.2. | Phase II | I-Chen Wu | 崔雅潔 | On-going |
| Periodontics | Comparison of collagen matrix and connective tissue grafts in the treatment of gingival recession: a clinical study | Class II | Yu-Hsiang Chou | On-going | ||
| Non-Small Cell Lung Cancer | Chest Medicine | Subcutaneous Methotrexate, Oral Dexamethasone or Oral Montelukast for the Prevention of Infusion Related Reaction Associated with Amivantamab, an EGFR-MET bispecific antibody, Among Post-osimertinib Treated EGFRm NSCLC; SKIPPirr, a Phase 2 Study | Phase II | Jen-Yu Hung | 陳怡伶 | On-going |
| Non-Small Cell Lung Cancer | Chest Medicine | A Randomized, Open-label, Phase 3 Study of MK-2870 vs Chemotherapy (Docetaxel or Pemetrexed) in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) with EGFR Mutations or Other Genomic Alterations | Phase III | Chih-Jen Yang | 蔡詠翔 | On-going |
| Asthma | Chest Medicine | A Phase 2a Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AZD4604 Twice Daily for Twelve Weeks in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA | Phase II | Chau-Chyun Sheu | 鄭宇喬 | On-going |
| Non-Small Cell Lung Cancer | Chest Medicine | A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) (eVOLVE?Lung02) | Phase III | Jen-Yu Hung | 陳怡伶 | On-going |
| 角膜塑型 | Ophthalmology | SmartLens Overnight Orthokeratology Contact Lenses Clinical Study | Class III | Shiuh-Liang Hsu | 李貞德 | On-going |
| Chronic Obstructive Pulmonary Disease | Chest Medicine | A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations (PROSPERO) | Phase III | Chau-Chyun Sheu | 吳珮驊 | On-going |
| Hematology and Oncology | Establishment of a novel manufacturing process for EBV-specific cytotoxic T cells from EBV-associated malignancies. | -- | Yi-Chang Liu | 陳亭玉 | On-going | |
| 惡性胸膜間皮瘤 | Chest Medicine | A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed Versus Platinum plus Pemetrexed or Nivolumab plus Ipilimumab in Participants with Unresectable Pleural Mesothelioma (eVOLVE-Meso) | Phase III | Chih-Jen Yang | 蔡詠翔 | On-going |
← Please slide to the left for more information